2nd Quarter - Report — BUCHANAN INGERSOLL & ROONEY PC for CRO, LLC (2022)

Firm

BUCHANAN INGERSOLL & ROONEY PC

Client

CRO, LLC

Income

$20,000

Expenses

—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

Strategy development and implementation of federal government relations initiatives relating to antivenom biologic products.

Lobbyist	Covered position, as disclosed
EDWARD HILD	Chief of Staff, Sen. Lisa Murkowski; Legislative Director, Sen. Pete Domenici
JAMES C WILTRAUT	—

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Defense, Dept of (DOD); SENATE

Defense DEF

Strategy development and implementation of federal government relations initiatives relating to antivenom biologic products.

Lobbyist	Covered position, as disclosed
EDWARD HILD	Chief of Staff, Sen. Lisa Murkowski; Legislative Director, Sen. Pete Domenici

Contacted: Defense, Dept of (DOD); Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

Strategy development and implementation of federal government relations initiatives relating to antivenom biologic products.

Lobbyist	Covered position, as disclosed
EDWARD HILD	Chief of Staff, Sen. Lisa Murkowski; Legislative Director, Sen. Pete Domenici
JAMES C WILTRAUT	—

Contacted: Defense, Dept of (DOD); SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Medical/Disease Research/Clinical Labs MED

Strategy development and implementation of federal government relations initiatives relating to antivenom biologic products.

Lobbyist	Covered position, as disclosed
EDWARD HILD	Chief of Staff, Sen. Lisa Murkowski; Legislative Director, Sen. Pete Domenici
JAMES C WILTRAUT	—

Contacted: SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Defense, Dept of (DOD)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.